To compare the efficacy of remnant ablation following a single low dose versus a single high dose of iodine-131 (I-131) in patients with differentiated thyroid cancer, and to determine whether or not the extent of surgery influences the outcome.
Participants included in the review
Studies of patients who had received surgery for differentiated thyroid cancer were eligible for inclusion in the review. Patients not eligible for inclusion were: patients with medullary, anaplastic or poorly differentiated carcinomas who were not given radioiodine; patients who presented with distant metastases; and patients who received their first dose of I-131 more than 12 months after surgery. The studies included patients who had received total, near-total and sub-total thyroidectomy.
Outcomes assessed in the review
Studies in which the relative risk of failure of remnant ablation associated with dose levels of I-131 could be calculated were eligible for inclusion. The studies had to have assessed the outcome after the first I-131 ablation post-surgery with clear criteria. The studies also had to have performed whole body scanning between 3 and 12 months after the therapeutic dose of I-131. The criteria for successful ablation used in the included studies varied; details were provided in the paper.
How were decisions on the relevance of primary studies made?
The two authors independently assessed studies for inclusion in the review. They did not state how any disagreements were resolved.
Results of the review
Eleven published studies (n=809) were included in the review, along with a cohort of patients seen by one of the authors; the cohort (n=158) was split into two groups according to type of thyroidectomy procedure. The 11 published studies comprised 3 RCTs and 8 cohort studies.
The pooled RR of nonablation after the first dose of I-131 was 0.73 (95% CI: 0.61, 0.87), indicating that high-dose patients have a statistically significantly lower risk of nonablation than low-dose patients after the first dose. There was no significant heterogeneity between the studies (Cochran Q test, P=0.76). Assuming the average risk of failure of ablation with low-dose I-131 is about 50%, then the absolute reduction in risk with high-dose I-131 would be 15%. The number of patients that would need-to-be-treated with high dose I-131 in order to prevent one ablation failure would be about seven.
The pooled RR was 0.69 (95% CI: 0.57, 0.84) for the cohort studies and 0.9 (95% CI: 0.6, 1.3) for the RCTs, using both the fixed-effect and random-effects models. Smaller studies, studies in which the risk of failure in the low-dose group was higher, and studies published in 1987 or earlier had a lower pooled RR. However, none of the sensitivity analyses produced significantly different results from the main analysis.
Egger's regression suggested that publication bias was present.
Authors' conclusions
High-dose I-131 (in the region of 2,775 to 3,700 MBq) is more efficient than low dose I-131 for remnant ablation, particularly after less than total thyroidectomy.
CRD commentary
The review question was clear in terms of the study designs, interventions, participants and outcomes of interest. However, the authors stated that only published RCTs and cohort studies were eligible for the review, yet included a cohort of their own patients. The authors undertook a limited search and only studies published in English were included, thereby increasing the potential for language bias and publication bias; an assessment of publication bias suggested that it was present. Two reviewers independently assessed studies for inclusion in the review, which helps reduce the potential for errors and reviewer bias. However, the authors did not state how the data were extracted from the included studies, thus the potential for errors and reviewer bias in this process cannot be assessed. The included studies were not assessed for quality and this may affect the validity of the results. Adequate details of the included studies were presented. The authors assessed statistical heterogeneity and performed sensitivity analyses. The methods used to combine the studies appear appropriate. Owing to the lack of a validity assessment, the potential for reviewer error or bias and language bias, and the presence of publication bias, the authors' conclusions should be interpreted with caution.
